SEC-sourced researchBeta
CERS
CERUS CORP
Company comparison ↗
Data passport
- CIK
- 0001020214
- Exchange
- Nasdaq
- Business activity
- Surgical & Medical Instruments & Apparatus · SIC 3841
- Financial inputs
- 6/6
- Filing date
- Nov 13, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 186,797,000.0000 | Mar 2, 2026 |
| December 2024 | 201,321,000.0000 | Mar 2, 2026 |
| December 2025 | 233,798,000.0000 | Mar 2, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 233,798,000.0000 | -15,627,000.0000 | 4,837,000.0000 | 221,859,000.0000 | 156,894,000.0000 | Mar 2, 2026 |
| December 2024 | 201,321,000.0000 | -20,918,000.0000 | 11,359,000.0000 | 200,917,000.0000 | 144,021,000.0000 | Mar 2, 2026 |
| December 2023 | 186,797,000.0000 | -37,489,000.0000 | -43,168,000.0000 | — | — | Mar 2, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
57/100
Profitability37
Growth66
Balance sheet29
Cash generation54
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $233.8M | Jan 1, 2025 – Dec 31, 2025 | Mar 2, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $201.32M | Jan 1, 2024 – Dec 31, 2024 | Mar 2, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$15.63M | Jan 1, 2025 – Dec 31, 2025 | Mar 2, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $4.84M | Jan 1, 2025 – Dec 31, 2025 | Mar 2, 2026 | 10-K |
| Total assetsAssets | $221.86M | Dec 31, 2025 | Mar 2, 2026 | 10-K |
| Total liabilitiesLiabilities | $156.89M | Dec 31, 2025 | Mar 2, 2026 | 10-K |